GB9928542D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB9928542D0
GB9928542D0 GBGB9928542.1A GB9928542A GB9928542D0 GB 9928542 D0 GB9928542 D0 GB 9928542D0 GB 9928542 A GB9928542 A GB 9928542A GB 9928542 D0 GB9928542 D0 GB 9928542D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9928542.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenova Ltd
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Priority to GBGB9928542.1A priority Critical patent/GB9928542D0/en
Publication of GB9928542D0 publication Critical patent/GB9928542D0/en
Priority to AU17184/01A priority patent/AU784397B2/en
Priority to HU0300392A priority patent/HUP0300392A3/en
Priority to BR0016093-8A priority patent/BR0016093A/en
Priority to MYPI20005670A priority patent/MY136029A/en
Priority to CNB008187096A priority patent/CN1304380C/en
Priority to US10/148,601 priority patent/US20030139409A1/en
Priority to CA002392873A priority patent/CA2392873A1/en
Priority to JP2001547068A priority patent/JP2003518103A/en
Priority to EP00979799A priority patent/EP1240148A1/en
Priority to PL00356482A priority patent/PL356482A1/en
Priority to MXPA02005476A priority patent/MXPA02005476A/en
Priority to KR1020027007033A priority patent/KR100767613B1/en
Priority to PCT/GB2000/004609 priority patent/WO2001046157A1/en
Priority to GB0215275A priority patent/GB2373499B/en
Priority to TW089125715A priority patent/TWI280242B/en
Priority to ZA200204296A priority patent/ZA200204296B/en
Priority to HK02107392.7A priority patent/HK1046133B/en
Priority to US11/024,759 priority patent/US7132419B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/46—Phenazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
GBGB9928542.1A 1999-12-02 1999-12-02 Pharmaceutical compounds Ceased GB9928542D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB9928542.1A GB9928542D0 (en) 1999-12-02 1999-12-02 Pharmaceutical compounds
GB0215275A GB2373499B (en) 1999-12-02 2000-12-01 Pharmaceutical compounds
JP2001547068A JP2003518103A (en) 1999-12-02 2000-12-01 Benzo [A] phenazine-11-carboxamide derivatives and their use as co-inhibitors of topomerase I and II
PL00356482A PL356482A1 (en) 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii
BR0016093-8A BR0016093A (en) 1999-12-02 2000-12-01 Compound, process to produce the same, use of a compound, and pharmaceutical composition
MYPI20005670A MY136029A (en) 1999-12-02 2000-12-01 Pharmaceutical compounds
CNB008187096A CN1304380C (en) 1999-12-02 2000-12-01 Benzo[a]henazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II
US10/148,601 US20030139409A1 (en) 1999-12-02 2000-12-01 Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II
CA002392873A CA2392873A1 (en) 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii
AU17184/01A AU784397B2 (en) 1999-12-02 2000-12-01 Benzo(A)phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II
EP00979799A EP1240148A1 (en) 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii
HU0300392A HUP0300392A3 (en) 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide derivatives, their use for producing pharmaceutical compositions with effect joint inhibitors of topomerase i and ii, process for their preparation and their intermediates
MXPA02005476A MXPA02005476A (en) 1999-12-02 2000-12-01 Benzo[a]phenazin 11 carboxamide derivatives and their use as joint inhibitors of topomerase i and ii.
KR1020027007033A KR100767613B1 (en) 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide compounds, their preparation and pharmaceutical compositions comprising them
PCT/GB2000/004609 WO2001046157A1 (en) 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii
TW089125715A TWI280242B (en) 1999-12-02 2000-12-02 Pharmaceutical compounds
ZA200204296A ZA200204296B (en) 1999-12-02 2002-05-29 Benzo(a) phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II.
HK02107392.7A HK1046133B (en) 1999-12-02 2002-10-10 Pharmaceutical compounds
US11/024,759 US7132419B2 (en) 1999-12-02 2004-12-30 Pharmaceutical compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9928542.1A GB9928542D0 (en) 1999-12-02 1999-12-02 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB9928542D0 true GB9928542D0 (en) 2000-02-02

Family

ID=10865607

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9928542.1A Ceased GB9928542D0 (en) 1999-12-02 1999-12-02 Pharmaceutical compounds
GB0215275A Expired - Fee Related GB2373499B (en) 1999-12-02 2000-12-01 Pharmaceutical compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0215275A Expired - Fee Related GB2373499B (en) 1999-12-02 2000-12-01 Pharmaceutical compounds

Country Status (16)

Country Link
EP (1) EP1240148A1 (en)
JP (1) JP2003518103A (en)
KR (1) KR100767613B1 (en)
CN (1) CN1304380C (en)
AU (1) AU784397B2 (en)
BR (1) BR0016093A (en)
CA (1) CA2392873A1 (en)
GB (2) GB9928542D0 (en)
HK (1) HK1046133B (en)
HU (1) HUP0300392A3 (en)
MX (1) MXPA02005476A (en)
MY (1) MY136029A (en)
PL (1) PL356482A1 (en)
TW (1) TWI280242B (en)
WO (1) WO2001046157A1 (en)
ZA (1) ZA200204296B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2433071A (en) * 2005-12-05 2007-06-13 Kontrakt Technology Ltd Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell
CN102898388B (en) * 2012-09-26 2014-12-03 浙江工业大学 Method for synthesizing substituted benzo[alpha]phenazine compound
CN103360329B (en) * 2013-07-18 2015-11-18 中国科学院南海海洋研究所 One class compound phenazine and preparing the application in antitumor drug
CN106554321B (en) * 2015-09-25 2019-05-28 陆源 A kind of azophenlyene substance, preparation method and its application
CN113461623A (en) * 2021-07-14 2021-10-01 长江大学 Antiviral compound and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696131A (en) * 1993-01-22 1997-12-09 Xenova Limited Treatment of cancers
DE69329336D1 (en) * 1992-05-28 2000-10-05 Xenova Ltd ACRIDIN CARBOXAMIDE FOR TREATING CANCER
PL332416A1 (en) * 1996-09-23 1999-09-13 Rutgers Substituted heterocyclic compounds as anticarcinogenic agents
WO1998045272A1 (en) * 1997-04-07 1998-10-15 Latrobe University Topoisomerase inhibitors

Also Published As

Publication number Publication date
ZA200204296B (en) 2003-05-29
KR100767613B1 (en) 2007-10-19
TWI280242B (en) 2007-05-01
WO2001046157A1 (en) 2001-06-28
EP1240148A1 (en) 2002-09-18
HK1046133B (en) 2005-04-15
JP2003518103A (en) 2003-06-03
GB0215275D0 (en) 2002-08-14
MXPA02005476A (en) 2003-09-22
KR20020070305A (en) 2002-09-05
CA2392873A1 (en) 2001-06-28
CN1433406A (en) 2003-07-30
HUP0300392A3 (en) 2003-09-29
MY136029A (en) 2008-07-31
CN1304380C (en) 2007-03-14
HUP0300392A2 (en) 2003-07-28
BR0016093A (en) 2002-08-20
GB2373499A (en) 2002-09-25
AU1718401A (en) 2001-07-03
HK1046133A1 (en) 2002-12-27
AU784397B2 (en) 2006-03-23
GB2373499B (en) 2004-11-17
PL356482A1 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
GB9817118D0 (en) Pharmaceutical compounds
PL351387A1 (en) Pharmaceutical composition
AU1071301A (en) Pharmaceutical compounds
GB9817623D0 (en) Pharmaceutical compounds
GB9810886D0 (en) Pharmaceutical compounds
PL351686A1 (en) Novel pharmaceutical
HUP0203585A3 (en) Pharmaceutical combinations
IL145632A0 (en) Pharmaceutical compounds
GB0031084D0 (en) Pharmaceutical compounds
EG23937A (en) Novel pharmaceutical
GB9916434D0 (en) Pharmaceutical compounds
GB9914255D0 (en) Pharmaceutical compounds
GB9909041D0 (en) Novel pharmaceutical
GB9823847D0 (en) Pharmaceutical compounds
GB9903784D0 (en) Pharmaceutical compounds
GB9823845D0 (en) Pharmaceutical compounds
IL146341A0 (en) Pharmaceutical complex
EG23946A (en) Novel pharmaceutical
GB0019272D0 (en) Pharmaceutical compounds
GB2373499B (en) Pharmaceutical compounds
GB0024318D0 (en) Pharmaceutical compounds
GB9817197D0 (en) Pharmaceutical compounds
GB0005366D0 (en) Pharmaceutical compounds
GB9923933D0 (en) Novel pharmaceutical
SI1252133T1 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)